KVUE:NYSE
Kenvue Inc
US$17,76
arrow_downward
-0,39%(-0,070) 1D
US$17,71
arrow_downward
-0,26% (-0,047)bedtimeAfter hours
Closed: 13 ຕ.ລ., 16 ໂມງ 0 ນາທີ 05 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KVUE...
Open
US$17,91
High
US$17,94
Low
US$17,54
Mkt. cap
34,11 ຕື້
Avg. vol.
24,19 ລ້ານ
Volume
0,00
Dividend
4,73%
Quarterly dividend
US$0,21
Ex-dividend date
21 ກ.ຍ. 2026
P/E ratio
20,59
52-wk high
US$20,13
52-wk low
US$14,02
EPS
US$0,86
Beta
0,48
Shares outstanding
1,92 ຕື້
No. of employees
22 ພັນ
Open
US$17,91
High
US$17,94
Low
US$17,54
Mkt. cap
34,11 ຕື້
Avg. vol.
24,19 ລ້ານ
Volume
0,00
Dividend
4,73%
Quarterly dividend
US$0,21
Ex-dividend date
21 ກ.ຍ. 2026
P/E ratio
20,59
52-wk high
US$20,13
52-wk low
US$14,02
EPS
US$0,86
Beta
0,48
Shares outstanding
1,92 ຕື້
No. of employees
22 ພັນ
News stories
From web sources and news partners
CNBC
·
14 ຊົ່ວໂມງກ່ອນ
We're adding to a consumer staples stock in advance of a big catalyst
Reuters
·
14 ຊົ່ວໂມງກ່ອນ
EU approves Kimberly-Clark's $40 billion Kenvue acquisition
News Corp
·
15 ຊົ່ວໂມງກ່ອນ
Kimberly-Clark, Kenvue Win Conditional EU Approval for $40 Billion Tie-Up
Investing.com South Africa
·
15 ຊົ່ວໂມງກ່ອນ
Kimberly-Clark wins EU approval for Kenvue acquisition By Investing.com
Profile
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index.
CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
About Kenvue Inc
CEOKirk Perry
Employees21,9 ພັນ
Founded2022
HeadquartersSummit, ນິວເຈີຊີ, ສະຫະລັດ
SectorPersonal care products
Websitekenvue.com